1 Study Coverage
1.1 Methylphenidate Product Introduction
1.2 Global Methylphenidate Outlook 2017 VS 2022 VS 2028
1.2.1 Global Methylphenidate Sales in US$ Million for the Year 2017-2028
1.2.2 Global Methylphenidate Sales in Volume for the Year 2017-2028
1.3 United States Methylphenidate Outlook 2017 VS 2022 VS 2028
1.3.1 United States Methylphenidate Sales in US$ Million for the Year 2017-2028
1.3.2 United States Methylphenidate Sales in Volume for the Year 2017-2028
1.4 Methylphenidate Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Methylphenidate in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Methylphenidate Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Methylphenidate Market Dynamics
1.5.1 Methylphenidate Industry Trends
1.5.2 Methylphenidate Market Drivers
1.5.3 Methylphenidate Market Challenges
1.5.4 Methylphenidate Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Methylphenidate Market Segment by Type
2.1.1 Tablet
2.1.2 Capsule
2.1.3 Others
2.2 Global Methylphenidate Market Size by Type
2.2.1 Global Methylphenidate Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Methylphenidate Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Methylphenidate Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Methylphenidate Market Size by Type
2.3.1 United States Methylphenidate Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Methylphenidate Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Methylphenidate Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Methylphenidate Market Segment by Application
3.1.1 Attention deficit hyperactivity disorder
3.1.2 Narcolepsy
3.1.3 Other
3.2 Global Methylphenidate Market Size by Application
3.2.1 Global Methylphenidate Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Methylphenidate Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Methylphenidate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Methylphenidate Market Size by Application
3.3.1 United States Methylphenidate Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Methylphenidate Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Methylphenidate Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Methylphenidate Competitor Landscape by Company
4.1 Global Methylphenidate Market Size by Company
4.1.1 Top Global Methylphenidate Manufacturers Ranked by Revenue (2021)
4.1.2 Global Methylphenidate Revenue by Manufacturer (2017-2022)
4.1.3 Global Methylphenidate Sales by Manufacturer (2017-2022)
4.1.4 Global Methylphenidate Price by Manufacturer (2017-2022)
4.2 Global Methylphenidate Concentration Ratio (CR)
4.2.1 Methylphenidate Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Methylphenidate in 2021
4.2.3 Global Methylphenidate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Methylphenidate Manufacturing Base Distribution, Product Type
4.3.1 Global Methylphenidate Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Methylphenidate Product Type
4.3.3 Date of International Manufacturers Enter into Methylphenidate Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Methylphenidate Market Size by Company
4.5.1 Top Methylphenidate Players in United States, Ranked by Revenue (2021)
4.5.2 United States Methylphenidate Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Methylphenidate Sales by Players (2020, 2021 & 2022)
5 Global Methylphenidate Market Size by Region
5.1 Global Methylphenidate Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Methylphenidate Market Size in Volume by Region (2017-2028)
5.2.1 Global Methylphenidate Sales in Volume by Region: 2017-2022
5.2.2 Global Methylphenidate Sales in Volume Forecast by Region (2023-2028)
5.3 Global Methylphenidate Market Size in Value by Region (2017-2028)
5.3.1 Global Methylphenidate Sales in Value by Region: 2017-2022
5.3.2 Global Methylphenidate Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Methylphenidate Market Size YoY Growth 2017-2028
6.1.2 North America Methylphenidate Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Methylphenidate Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Methylphenidate Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Methylphenidate Market Size YoY Growth 2017-2028
6.3.2 Europe Methylphenidate Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Methylphenidate Market Size YoY Growth 2017-2028
6.4.2 Latin America Methylphenidate Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Methylphenidate Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Methylphenidate Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Methylphenidate Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Methylphenidate Products Offered
7.1.5 Pfizer Recent Development
7.2 Teva
7.2.1 Teva Corporation Information
7.2.2 Teva Description and Business Overview
7.2.3 Teva Methylphenidate Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Teva Methylphenidate Products Offered
7.2.5 Teva Recent Development
7.3 Novartis
7.3.1 Novartis Corporation Information
7.3.2 Novartis Description and Business Overview
7.3.3 Novartis Methylphenidate Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis Methylphenidate Products Offered
7.3.5 Novartis Recent Development
7.4 Sandoz
7.4.1 Sandoz Corporation Information
7.4.2 Sandoz Description and Business Overview
7.4.3 Sandoz Methylphenidate Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sandoz Methylphenidate Products Offered
7.4.5 Sandoz Recent Development
7.5 GSK
7.5.1 GSK Corporation Information
7.5.2 GSK Description and Business Overview
7.5.3 GSK Methylphenidate Sales, Revenue and Gross Margin (2017-2022)
7.5.4 GSK Methylphenidate Products Offered
7.5.5 GSK Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Methylphenidate Industry Chain Analysis
8.2 Methylphenidate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Methylphenidate Distributors
8.3 Methylphenidate Production Mode & Process
8.4 Methylphenidate Sales and Marketing
8.4.1 Methylphenidate Sales Channels
8.4.2 Methylphenidate Distributors
8.5 Methylphenidate Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Methylphenidate CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Methylphenidate Market Trends
Table 3. Methylphenidate Market Drivers
Table 4. Methylphenidate Market Challenges
Table 5. Methylphenidate Market Restraints
Table 6. Global Methylphenidate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Methylphenidate Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Methylphenidate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Methylphenidate Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Methylphenidate Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Methylphenidate Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Methylphenidate Revenue Share by Manufacturer, 2017-2022
Table 13. Global Methylphenidate Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Methylphenidate Sales Share by Manufacturer, 2017-2022
Table 15. Global Methylphenidate Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Methylphenidate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Methylphenidate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methylphenidate as of 2021)
Table 18. Top Players of Methylphenidate in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Methylphenidate Product Type
Table 20. Date of International Manufacturers Enter into Methylphenidate Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Methylphenidate Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Methylphenidate Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Methylphenidate Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Methylphenidate Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Methylphenidate Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Methylphenidate Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Methylphenidate Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Methylphenidate Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Methylphenidate Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Methylphenidate Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Methylphenidate Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Methylphenidate Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Methylphenidate Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Methylphenidate Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Methylphenidate Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Methylphenidate Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Methylphenidate Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Methylphenidate Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Methylphenidate Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Methylphenidate Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Corporation Information
Table 43. Pfizer Description and Business Overview
Table 44. Pfizer Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Pfizer Methylphenidate Product
Table 46. Pfizer Recent Development
Table 47. Teva Corporation Information
Table 48. Teva Description and Business Overview
Table 49. Teva Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Teva Product
Table 51. Teva Recent Development
Table 52. Novartis Corporation Information
Table 53. Novartis Description and Business Overview
Table 54. Novartis Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Novartis Product
Table 56. Novartis Recent Development
Table 57. Sandoz Corporation Information
Table 58. Sandoz Description and Business Overview
Table 59. Sandoz Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Sandoz Product
Table 61. Sandoz Recent Development
Table 62. GSK Corporation Information
Table 63. GSK Description and Business Overview
Table 64. GSK Methylphenidate Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. GSK Product
Table 66. GSK Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Methylphenidate Customers List
Table 70. Methylphenidate Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Methylphenidate Product Picture
Figure 2. Global Methylphenidate Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Methylphenidate Market Size 2017-2028 (US$ Million)
Figure 4. Global Methylphenidate Sales 2017-2028 (K MT)
Figure 5. United States Methylphenidate Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Methylphenidate Market Size 2017-2028 (US$ Million)
Figure 7. United States Methylphenidate Sales 2017-2028 (K MT)
Figure 8. United States Methylphenidate Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Methylphenidate Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Methylphenidate Report Years Considered
Figure 11. Product Picture of Tablet
Figure 12. Product Picture of Capsule
Figure 13. Product Picture of Others
Figure 14. Global Methylphenidate Market Share by Type in 2022 & 2028
Figure 15. Global Methylphenidate Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Methylphenidate Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Methylphenidate Sales by Type (2017-2028) & (K MT)
Figure 18. Global Methylphenidate Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Methylphenidate Price by Type (2017-2028) & (USD/MT)
Figure 20. United States Methylphenidate Market Share by Type in 2022 & 2028
Figure 21. United States Methylphenidate Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Methylphenidate Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Methylphenidate Sales by Type (2017-2028) & (K MT)
Figure 24. United States Methylphenidate Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Methylphenidate Price by Type (2017-2028) & (USD/MT)
Figure 26. Product Picture of Attention deficit hyperactivity disorder
Figure 27. Product Picture of Narcolepsy
Figure 28. Product Picture of Other
Figure 29. Global Methylphenidate Market Share by Application in 2022 & 2028
Figure 30. Global Methylphenidate Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Methylphenidate Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Methylphenidate Sales by Application (2017-2028) & (K MT)
Figure 33. Global Methylphenidate Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Methylphenidate Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Methylphenidate Market Share by Application in 2022 & 2028
Figure 36. United States Methylphenidate Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Methylphenidate Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Methylphenidate Sales by Application (2017-2028) & (K MT)
Figure 39. United States Methylphenidate Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Methylphenidate Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Methylphenidate Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Methylphenidate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Methylphenidate Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Methylphenidate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Methylphenidate Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Methylphenidate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. China Taiwan Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Methylphenidate Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Methylphenidate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Methylphenidate Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 69. Middle East & Africa Methylphenidate Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. UAE Methylphenidate Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Methylphenidate Value Chain
Figure 74. Methylphenidate Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Teva Novartis Sandoz GSK